Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29640378 | 0.86 | GAA (0.45) | KMT2AMEN1MAPTTSHRALDH1A1 | |
| SCHEMBL3083039 | 0.84 | MAPT (0.39) | TAAR1SMN1; SMN2KMT2ACYP1A2CYP3A4 | |
| SCHEMBL22342192 | 0.82 | FFAR1 (0.40) | TAAR1SMN1; SMN2MAPTTSHRACHE | |
| SCHEMBL775626 | 0.82 | TAAR1 (0.50) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL777337 | 0.82 | ALDH1A1 (0.56) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL8757216 | 0.78 | TAAR1 (0.46) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL21654563 | 0.78 | TAAR1 (0.46) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL1145828 | 0.78 | TAAR1 (0.46) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL9976776 | 0.78 | TAAR1 (0.46) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 | |
| SCHEMBL30139921 | 0.78 | TAAR1 (0.52) | TAAR1SMN1; SMN2KMT2AMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119717396-A | Photosensitive resin composition baked at low temperature and use thereof | 台湾永光化学工业股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| EP-4081597-A1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | Cytec Industries, Inc. (US) | 2022-11-02 | — | — | EP | claimed |
| WO-2021133972-A1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | CYTEC INDUSTRIES INC. (US) | 2021-07-01 | — | — | WO | claimed |
| US-20070015755-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2007-01-18 | — | — | US | claimed |
| EP-1452522-A2 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2004-09-01 | — | — | EP | claimed |
| US-20040147745-A1 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2004-07-29 | — | — | US | claimed |
| EP-1178958-B1 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARM INC (US) | 2004-02-18 | — | — | EP | claimed |
| US-20030096796-A1 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2003-05-22 | — | — | US | claimed |
| JP-2002539191-A | — | — | 2002-11-19 | — | — | JP | claimed |
| US-6455502-B1 | Compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. | 2002-09-24 | — | — | US | claimed |
| EP-1178958-A2 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-02-13 | — | — | EP | claimed |
| WO-2000055125-A2 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| US-12435237-B2 | UV resistant surfacing materials for composite parts | CYTEC INDUSTRIES INC. (US) | 2025-10-07 | — | — | US | disclosed |
| WO-2025094854-A1 | METHOD FOR PRODUCING POLYACID SALTS OR MIXTURES THEREOF, AND METHOD FOR REMOVING IMPURITIES | 東京応化工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| CN-119717396-A | Photosensitive resin composition baked at low temperature and use thereof | 台湾永光化学工业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118076706-A | Color-changeable adhesive sheet and coloring method thereof | 日东电工株式会社 | 2024-05-24 | — | — | CN | disclosed |
| EP-1178958-A2 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-02-13 | — | — | EP | disclosed |
| EP-1112251-A1 | AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000055125-A2 | N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000015609-A1 | AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | AVENTIS PHARMA S.A. (FR) | 2000-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096796-A1 | Novel compounds and compositions as protease inhibitors | CTRL, SERPINB1, CPN1 | TAAR1 4777/4885SMN1; SMN2 3462/4885KMT2A 2983/4885 |
| US-20040147745-A1 | Novel compounds and compositions as protease inhibitors | CTRL, SERPINB1, CPN1 | TAAR1 4777/4885SMN1; SMN2 3462/4885KMT2A 2983/4885 |
| US-20070015755-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | CTRL, SERPINB1, CPN1 | TAAR1 4777/4885SMN1; SMN2 3462/4885KMT2A 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.